Biopharma Layoff Tracker 2024. At the end of june, at least 54 companies had reported. Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024.
The reorganization includes cutting about. The company’s layoffs follow plans by swiss drugmaker novartis to shed as many as 8,000 employees worldwide.
While This Is Not A New Trend, The Current Trajectory Is.
Year of biotech layoffs leaves industry looking for spark.
2023 Was A Year Of Economic Uncertainty For The Biotech Industry, Which Led To A Funding Drought.
[ updated on march 22, 2024 ] on the heels of a strong year of.
The Company’s Layoffs Follow Plans By Swiss Drugmaker Novartis To Shed As Many As 8,000 Employees Worldwide.
Images References :
Analysis Highlights Impact On Key Industry Hubs.
If no information was available, layoffs are pinned to the company’s global or regional headquarters.
The Company’s Layoffs Follow Plans By Swiss Drugmaker Novartis To Shed As Many As 8,000 Employees Worldwide.
More than 115 biotech companies have announced layoffs this year, on track to easily surpass 2022’s numbers.
Notably, Our Map Shows Only Companies With A Market Cap Of At Least $2.
